Total Sample (n = 66) Mean ± SD or %, (n) No Atrial Fibrillation (n = 44) Mean ± SD or %, (n) Atrial Fibrillation (n = 22) Mean ± SD or %, (n)
Age* 68.1 ± 11.5 (66) 65.1 ± 11.1 (44) 74.1 ± 9.9 (22)
Ibrutinib Dose* 428.5 ± 103.8 (66) 448.6 ± 88.4 (44) 388.2 ± 121.7 (22)
BMI 27.5 ± 5.8 (66) 28.1 ± 6.3 (44) 26.2 ± 4.6 (22)
Sex, % (n)
Male 65.2 (43) 61.4 (27) 72.7 (16)
Female 34.8 (23) 38.6 (17) 27.3 (6)
Race/Ethnicity, % (n)
Non-Hispanic White 74.2 (49) 77.3 (34) 68.2 (15)
Non-Hispanic Black 7.6 (5) 6.8 (3) 9.1 (2)
Other/Unknown 18.2 (12) 15.9 (7) 22.7 (5)
Comorbidities, % (n)
HTN 77.3 (51) 79.5 (35) 72.7 (16)
HLD 65.2 (43) 61.4 (27) 72.7 (16)
DM 28.8 (19) 13.6 (6) 59.1 (13)
CAD 19.7 (13) 15.9 (7) 27.3 (6)
HF 16.7 (10) 9.1 (4) 27.3 (6)
MR 1.5 (1) 0.0 (0) 1.5 (1)
AS 1.5 (1) 0.0 (0) 1.5 (1)
Malignancy, % (n)
CLL/SLL 53.0 (35) (22) (13)
Other Lymphoma 28.8 (19) (14) (5)
Plasma Cell Dyscrasia 16.7 (11) (8) (3)
Other 1.5 (1) (0) (1)